REG - ConvaTec Group PLC - Holding(s) in Company <Origin Href="QuoteRef">CTEC.L</Origin>

ConvaTecAnnouncement

09/06/2017 11:50

RNS Number : 6826H
ConvaTec Group PLC
09 June 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:ii
CONVATEC GROUP PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation:iii
NORDIC CAPITAL VI LIMITED
NORDIC CAPITAL VII LIMITED
4. Full name of shareholder(s)
(if different from 3.):iv
CIDRON HEALTHCARE TOPCO LIMITED 
CIDRON HEALTHCARE CO-INVEST LIMITED
CIDRON HEALTHCARE CO-INVEST II LIMITED
5. Date of the transaction and date on
which the threshold is crossed or
reached:v
8 JUNE 2017 
6. Date on which issuer notified:
9 JUNE 2017
7. Threshold(s) that is/are crossed or
reached: vi, vii
Below 8%
8. Notified details:
A: Voting rights attached to sharesviii, ix
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of voting rights x
Direct
Direct xi
Indirect xii
Direct
Indirect
ORDINARY SHARES OF 0.10 EACH
314,158,828
314,158,828
143,158,828
N/A
143,158,828
N/A
7.34%
GB00BD3VFW73
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date xiii
Exercise/
Conversion Period xiv
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights
N/A
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price
Expiration date xvii
Exercise/
Conversion period xviii
Number of voting rights instrument refers to
% of voting rights xix, xx
N/A
Nominal
Delta
Total (A+B+C)
Number of voting rights
Percentage of voting rights
143,158,828
7.34%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Nordic Capital VI Limited is the General Partner of Nordic Capital VI Alpha, L.P. and Nordic Capital VI Beta, L.P. (Fund VI) and is responsible for managing Fund VI.
Nordic Capital VII Limited is the General Partner of Nordic Capital VII Alpha, L.P. and Nordic Capital VII Beta, L.P. (Fund VII) and is responsible for managing Fund VII.
Fund VI and Fund VII hold shares in Cidron Healthcare Topco Limited (Topco). Topco in turn holds one management share in each of Cidron Healthcare Co-invest Limited and Cidron Healthcare Co-invest II Limited.
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease
to hold:
N/A
12. Date on which proxy holder will cease to hold
voting rights:
N/A

13. Additional information:
This disclosure has been calculated based on an issued share capital of 1,951,472,651 shares as disclosed by ConvaTec Group Plc in its AGM results announcement dated 11 May 2017.
14. Contact name:
LYNDA ELLIOTT
15. Contact telephone number:
+ 44 1534 605105

This information is provided by RNS
The company news service from the London Stock Exchange
  END
HOLEAEKNELLXEFF